Melatonin reduces protein and lipid oxidative damage induced by homocysteine in rat brain homogenates

Santiago Ortega-Gutiérrez1, Lorena Fuentes-Broto, Joaquín J García

  • 1Department of Pharmacology and Physiology, University of Zaragoza, Zaragoza, Spain.

Insights

Melatonin, a potent antioxidant, protects against homocysteine-induced oxidative damage in rat brain homogenates. This suggests melatonin may help prevent cardiovascular and cerebrovascular diseases linked to high homocysteine levels.

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Biochemistry

Background:

  • Hyperhomocysteinemia is a known risk factor for cardiovascular and cerebrovascular diseases.
  • Homocysteine (HCY) impairs cerebrovascular function by generating free radicals, contributing to oxidative stress.
  • Melatonin is recognized for its antioxidant properties and ability to reduce plasma HCY concentrations.

Purpose of the Study:

  • To investigate the protective effects of melatonin against homocysteine-induced protein and lipid oxidation in rat brain homogenates.
  • To determine if melatonin can mitigate oxidative damage caused by elevated homocysteine levels in neural tissue.

Main Methods:

  • Rat brain homogenates were prepared from Sprague-Dawley rats.
  • Homogenates were incubated with varying concentrations of homocysteine (HCY) and melatonin.
  • Protein oxidation was assessed by measuring carbonyl content; lipid oxidation was measured by quantifying malondialdehyde (MDA) and 4-hydroxyalkenals (4-HDA).

Main Results:

  • Homocysteine (0.01-5 mM) significantly increased protein carbonyl content and MDA+4-HDA formation in brain homogenates.
  • Melatonin demonstrated a concentration-dependent reduction in HCY-induced protein and lipid oxidation.
  • These findings indicate melatonin's efficacy in preventing oxidative damage in brain tissue.

Conclusions:

  • Melatonin effectively prevents homocysteine-induced oxidative damage to proteins and lipids in rat brain homogenates.
  • This antioxidant action represents a potential mechanism through which melatonin may reduce the risk of cardiovascular and cerebrovascular diseases associated with hyperhomocysteinemia.
  • Further research into melatonin's therapeutic potential for managing hyperhomocysteinemia-related conditions is warranted.

Related Concept Videos